HCV treatment decision-making substance use experiences and hepatitis C treatment decision-making among HIV/HCV Coinfected Adults.
HCV treatment decision-making substance use experiences and hepatitis C treatment decision-making among HIV/HCV Coinfected Adults.
复制标题
HIV/HCV 双重感染成人的 HCV 治疗决策物质使用经验和丙型肝炎治疗决策。
DOI：
10.1080/10826080802486897
复制
发表时间：
2009
影响因子：
2
通讯作者：
Bova,Carol
中科院分区：
文献类型：
--
作者：
Ogawa,LisaMFink;Bova,Carol
丙型肝炎病毒（HCV）感染是药物使用者和人类免疫缺陷病毒（HIV）感染者发病和死亡的主要原因。慢性HCV感染的治疗涉及复杂的决策。这些决定对于艾滋病毒感染者和药物使用相关问题的人来说甚至更加复杂。对在美国收集的定性数据的二次分析（2004-2005年），31例HIV/HCV合并感染成人（48%的女性;平均年龄44.7岁）揭示了与药物使用有关的三个主题（物质使用演变，旋转门：走出去，重建生活）和两个HCV治疗决策主题（HCV感染治疗问题：不是优先事项，恐惧，错误信息，清洁并尝试它）。研究的局限性和影响进行了讨论。
Hepatitis C virus (HCV) infection is a major source of morbidity and mortality among substance users and persons living with human immunodeficiency virus (HIV) infection. Treatment for chronic HCV infection involves complex decision-making. These decisions are even more complicated in persons with HIV and substance use related problems. A secondary analyses of qualitative data collected in the United States (2004–2005) with 31 HIV/HCV coinfected adults (48% women; mean age 44.7 years) revealed three themes related to substance use (substance use evolution, revolving door: going back out and reconstructing life) and two HCV treatment decision-making themes (HCV infection treatment issues: not a priority, fear, misinformation and get clean and try it). Study limitations and implications are discussed.